Document Detail


The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
MedLine Citation:
PMID:  12070755     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The neuropeptide neurotensin (NT) exerts a wide range of central and peripheral effects. In particular, ejection of NT (10(-7) M, 65 nl) into the ventral tegmental area (VTA) in anaesthetised rats pre-treated with pargyline increases the dopamine (DA) efflux within the nucleus accumbens (NAcc) as measured by differential pulse amperometry (DPA) combined with carbon fibre electrodes. However, this effect is not blocked by systemic pre-treatment with the potent and selective non-peptide NT receptor antagonists SR 48692 and SR 142948A, at any dose studied. The present study was designed to determine the ability of these NT receptor antagonists to block the increase in DA efflux evoked within the NAcc when they are locally applied with the peptide into the VTA. The competitive N-methyl- D-aspartate (NMDA) receptor antagonist, 2-amino-5-phosphonopentanoic acid (AP-5), applied into the VTA 1 min before NMDA, blocked the effect of NMDA on DA efflux concentration and volume dependently, thus demonstrating the suitability of our experimental procedure for characterizing both an agonist and an antagonist specific for receptors present on mesencephalic dopaminergic neurons and involved in the regulation of DA efflux within the NAcc. Intra-VTA application of SR 142948A blocked the NT-evoked increase in DA efflux within the NAcc dose dependently whereas SR 48692, at the concentration used, was inactive. These results suggest that NT regulates mesencephalic dopaminergic activity through NT receptors sensitive to SR 142948A, but possibly not to SR 48692.
Authors:
Maud Leonetti; Philippe Brun; Florence Sotty; Régis Steinberg; Philippe Soubrié; Lionel Bert; Bernard Renaud; Marie-Françoise Suaud-Chagny
Related Documents :
8737445 - (-)-stepholidine vs 12-chloroscoulerine enantiomers on firing activity of substantia ni...
2184375 - Cholecystokinin octapeptide potentiates the inhibitory response mediated by d2 dopamine...
17367945 - Distribution of serotonin 5-ht2c receptors in the ventral tegmental area.
15713275 - Dopamine manipulation alters immediate-early gene response of striatal parvalbumin inte...
18722485 - Membrane progestin receptors alpha and gamma in renal epithelium.
1933315 - Activation of nigral m1 and m2 muscarinic receptors produces opposing effects on striat...
Publication Detail:
Type:  Journal Article     Date:  2002-04-26
Journal Detail:
Title:  Naunyn-Schmiedeberg's archives of pharmacology     Volume:  365     ISSN:  0028-1298     ISO Abbreviation:  Naunyn Schmiedebergs Arch. Pharmacol.     Publication Date:  2002 Jun 
Date Detail:
Created Date:  2002-06-18     Completed Date:  2002-12-23     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  0326264     Medline TA:  Naunyn Schmiedebergs Arch Pharmacol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  427-33     Citation Subset:  IM    
Affiliation:
INSERM U 512, Laboratoire de Neuropharmacologie et Neurochimie, Faculté de Pharmacie, Université Claude Bernard, 8 avenue Rockefeller, 69373 Lyon Cedex 08, France. leonetti@rockefeller.univ-lyon1.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adamantane / analogs & derivatives*,  pharmacology*
Animals
Dopamine / secretion*
Imidazoles / pharmacology*
Male
N-Methylaspartate / pharmacology
Neurotensin / pharmacology*,  physiology
Nucleus Accumbens / drug effects*,  secretion
Rats
Rats, Sprague-Dawley
Receptors, Neurotensin / antagonists & inhibitors*,  physiology
Ventral Tegmental Area / drug effects*,  secretion
Chemical
Reg. No./Substance:
0/Imidazoles; 0/Receptors, Neurotensin; 0/SR 142948A; 281-23-2/Adamantane; 39379-15-2/Neurotensin; 6384-92-5/N-Methylaspartate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer.
Next Document:  Effects of prodelphinidins isolated from Ribes nigrum on chondrocyte metabolism and COX activity.